throbber
1
`Nature Vol. 256 August 7 I975
`
`
`Page 1
`
`Continuous cultures of fused cells
`secreting antibody of predefined specificity
`THE manufacture of predefined specific antibodies by means of
`permanent tissue culture cell lines is of general interest. There
`are at present a considerable number of permanent cultures of
`myeloma cells” and screening procedures have been used to
`reveal antibody activity in some of them. This, however,
`is
`not a satisfactory source of monoclonal antibodies of predefined
`specificity. We describe here the derivation of a number of
`tissue culture cell
`lines which secrete anti-sheep red blood
`cell (SRBC) antibodies. The cell lines are made by fusion of a
`mouse myeloma and mouse spleen cells from an immunised
`donor. To understand the expression and interactions of the
`Ig chains from the parental lines, fusion experiments between
`two known mouse myeloma lines were carried out.
`Each immunoglobulin chain results from the integrated
`expression of one of several Vand C genes coding respectively
`for its variable and constant sections. Each cell expresses only
`one of the two possible alleles (allelic exclusion; reviewed in
`ref. 3). When two antibody-producing cells are fused,
`the
`products of both parental lines are expressed”, and although
`the light and heavy chains of both parental lines are randomly
`joined, no evidence of scrambling of V and C sections is
`observed‘. These results, obtained in an heterologous system
`involving cells of rat and mouse origin, have now been con-
`firmed by fusing two myeloma cells of the same mouse strain,
`
`A
`
`Chains
`
`H(Pl)
`
`495
`
`The protein secreted (MOPC 21) is an lgG1 (K) which has been
`fully sequenced”. Equal numbers of cells from each parental
`line were fused using inactivated Sendai virus9 and samples
`contining 2><l05 cells were grown in selective medium in
`separate dishes. Four out of ten dishes showed growth in
`selective medium and these were taken as independent hybrid
`lines, probably derived from single fusion events. The karyotype
`of the hybrid cells after 5 months in culture was just under the
`sum of the two parental lines (Table I). Figure 1 shows the
`isoelectric focusing” (IEF) pattern of the secreted products of
`different lines. The hybrid cells (samples c—lz in Fig. 1) give a
`much more complex pattern than either parent (a and b) or a
`mixture of the parental lines (m). The important feature of the
`new pattern is the presence of extra bands (Fig.
`l, arrows).
`These new bands, however, do not seem to be the result of
`differences in primary structure; this is indicated by the IEF
`pattern of the products after reduction to separate the heavy
`and light chains (Fig. 1B). The IEF pattern of chains of the
`hybrid clones (Fig. 1B, g) is equivalent to the sum of the IEF
`pattern (a and b) of chains of the parental clones with no
`evidence of extra products. We conclude that, as previously
`shown with interspecies hybrids”, new lg molecules are
`produced as a result of mixed association between heavy and
`light chains from the two parents. This process is intracellular
`as a mixed cell population does not give rise to such hybrid
`molecules (compare m and g, Fig. IA). The individual cells must
`therefore be able to express both isotypes. This result shows
`that in hybrid cells the expression of one isotype and idiotype
`does not exclude the expression of another: both heavy chain
`
` Fig.
`
`1 Autoradiograph of labelled compo-
`nents secreted by the parental and hybrid cell
`lines analysed by IEF before (A) and after
`reduction (B). Cells were incubated in the
`presence of “C-lysine“ and the supernatant
`applied on polyacrylamide slabs. A, pH range
`6.0 (bottom) to 8.0 (top) in 4 M urea. B, pH
`range 5.0 (bottom) to 90 (top) in 6 M urea;
`the supernatant was incubated for 20 min at
`37 “C in the presence of 8 M urea, 1.5 M
`mercaptoethanol and 0.1 M potassium phos-
`phate pH 8.0 before being applied to the right
`slab. Supernatants from parental cell
`lines
`in: a, P1 Bu] ; b, P3-X67Ag8; and m, mixture
`of equal number of PlBul and P3-X67Ag8
`cells. Supernatants from two independently
`derived hybrid lines are shown: c-f, four
`subclones from Hy-3; g and h, two subclones
`from Hy-B. Fusion was carried out” using
`10"‘ cells of each parental
`line and 4,000
`haemagglutination units
`inactivated Sendai
`virus (Searle). Cells were divided into ten
`equal
`samples and grown separately in
`selective medium (HAT medium,
`ref. 6).
`Medium was changed every 3 d. Successful
`hybrid lines were obtained in four of the cul-
`tures, and all gave similar IEF patterns. Hy-B
`and Hy-3 were further cloned in soft agar“.
`L, Light; H, heavy.
`
`‘
`‘
`‘
`‘
`__ M v__,, __
`'
`
`2"‘
`
`/1
`
`*‘
`
`b
`
`g
`
`a
`
`and provide the background for the derivation and under-
`isotypes (yl and y2a) and both V” and both VL regions
`standing of antibody-secreting hybrid lines in which one of
`(idiotypes) are expressed. There are no allotypic markers for
`the parental cells is an antibody-producing spleen cell.
`the CK region to provide direct proof forthe expression of both
`Two myeloma cell lines of BALB/c origin were used. PlBul
`parental CK regions. But this is indicated by the phenotypic
`link between the Vand C regions.
`is resistant
`to 5-bromo-2’-deoxyuridine“, does not grow in
`Figure IA shows that clones derived from different hybridi-
`selective medium (HAT, ref. 6) and secretes a myeloma protein,
`Adj PCS, which is an lgG2A (K), (ref. 1). Synthesis is not
`sation experiments and from subclones of one line are indistin-
`balanced and free light chains are also secreted. The second
`guishable. This has also been observed in other experiments
`cell line, P3-X63Ag8, prepared from P3 cellsz,
`is resistant to
`(data not shown). Variants were, however, found in a survey of
`I00 subclones. The difference is often associated with changes
`20 ug ml" 8-azaguanine and d_o_e_s__n9_t grow in HAT medium.
`‘ ‘""
`GENENTECH 2003
`GENZYME V. GENENTECH
`©1975 Nature Publishing Group
`IPRZO 16-003 83
`
`GENENTECH 2003
`GENZYME V. GENENTECH
`IPR2016-00383
`
`

`
`496
`
`Nature Vol. 256 August 7 I975
`
`Isolation of an anti-SRBC antibody-
`Fig. 2
`secreting cell clone. Activity was revealed by
`a halo of haemolysed SRBC. Direct plaques
`given by: a, 6,000 hybrid cells Sp-1 ; b, clones
`grown in soft agar from an inoculum of 2,000
`Sp-1 cells; c, recloning of one of the positive
`clones Sp-1/7; a’, higher magnification of a
`positive clone. Myeloma cells (107 P3—X67A
`g8) were fused to 109 spleen cells from an
`immunised BALB/c mouse. Mice were im-
`munised by intraperitoneal injection of 0.2 ml
`packed SRBC diluted 1:10, boosted after 1
`month and the spleens collected 4 d later.
`After fusion, cells (Sp-l) were grown for 8 d
`in HAT medium, changed at 1-3 d intervals.
`Cells were then grown in Dulbecco modified
`Eagle’s medium, supplemented for 2 weeks
`with hypoxanthine and thymidine. Forty days
`after fusion the presence of anti-SRBC act-
`ivity was revealed as shown in a. The ratio of
`plaque forming cells/total number of hybrid
`cells was 1/30. This hybrid cell population
`was cloned in soft agar (50% cloning ef-
`ficiency). A modified plaque assay was used to
`reveal positive clones shown in b—a' as follows.
`When cell clones had reached a suitable size,
`they were overlaid in sterile conditions with
`2 ml 0.6% agarose in phosphate-buffered
`saline containing 25 ul packed SRBC and
`0.2 ml fresh guinea pig serum (absorbed with
`SRBC) as source of complement. b, Taken
`after overnight incubation at 37 “C. The ratio
`of positive/total number ofclones was 1/33. A
`suitable positive clone was picked out and
`grown in suspension. This clone was called
`Sp-I/7, and was recloned as shown in c; over
`90 % of the clones gave positive lysis. A second
`experiment in which 10“ P3- X67Ag8 cells were
`fused with 10*‘ spleen cells was the source of
`a clone giving rise to indirect plaques (clone
`Sp-2/3-3). Indirect plaques were produced by
`the addition of 1:20 sheep anti-MOPC 21
`antibody to the agarose overlay.
`
`in the ratios of the different chains and occasionally with the
`total‘ disappearance of one or other of the chains. Such events
`are best visualised on IEF analysis of the separated chains
`(for example, Fig.
`lh, in which the heavy chain of P3 is no
`longer observed). The important point that no new chains are
`detected by IEF complements a previous study“ of a rat—mouse
`hybrid line in which scrambling of V and C regions from the
`light chains of rat and mouse was not observed. In this study,
`both light chains have identical CK regions and therefore
`scrambled VL—CL molecules would be undetected. On the other
`hand,
`the heavy chains are of different subclasses and we
`expect scrambled VH—CH to be detectable by IEF. They were
`not observed in the clones studied and if they occur must do
`so at a lower frequency. We conclude that in syngeneic cell
`hybrids (as well as in interspecies cell hybrids) V—C integration is
`not the result of cytoplasmic events. Integration as a result of
`DNA translocation or rearrangement during transcription is
`also suggested by the presence of integrated mRNA molecules”
`and by the existence of defective heavy chains in which a
`deletion of V and C sections seems to take place in already
`committed cells”.
`The cell line P3-X63Ag8 described above dies when exposed
`to HAT medium. Spleen cells from an immunised mouse also
`die in growth medium. When both cells are fused by Sendai
`virus and the resulting mixture is grown in HAT medium,
`surviving clones can be observed to grow and become estab-
`lished after a few weeks. We have used SRBC as immunogen,
`which enabled us, after culturing the fused lines, to determine
`the presence of specific antibody-producing cells by a plaque
`assay technique” (Fig. 2a). The hybrid cells were cloned in
`soft agar“ and clones producing antibody were easily detected
`by an overlay of SRBC and complement (Fig. 2b). Individual
`clones were isolated and shown to retain their phenotype as
`almost all the clones of the derived purified line are capable of
`lysing SRBC (Fig. 2c). The clones were visible to the naked
`eye (for example, Fig. 2d). Both direct and indirect plaque
`
`assays” have been used to detect specific clones and representa-
`tive clones of both types have been characterised and studied.
`The derived lines (Sp hybrids) are hybrid cell lines for the
`following reasons. They grow in selective medium. Their
`karyotype after 4 months in culture (Table 1) is a little smaller
`than the sum of the two parental lines but more than twice the
`chromosome number of normal BALB/c cells, indicating that
`the lines are not the result of fusion between spleen cells. In
`addition the lines contain a metacentric chromosome also
`present
`in the parental P3 -X67Ag8. Finally,
`the secreted
`immunoglobulins contain MOPC 21 protein in addition to new,
`unknown components. The latter presumably represent
`the
`chains derived from the specific anti-SRBC antibody. Figure 3A
`shows the lEF pattern of the material secreted by two such
`Sp hybrid clones. The IEF bands derived from the parental P3
`line are visible in the pattern of the hybrid cells, although
`obscured by the presence of a number of new bands. The
`pattern is very complex, but the complexity of hybrids of this
`type is
`likely to result from the random recombination of
`chains (see above, Fig. 1). Indeed, IEF patterns of the reduced
`material secreted by the spleen—P3 hybrid clones gave a simpler
`pattern of lg chains. The heavy and light chains of the P3
`parental line became prominent, and new bands were apparent.
`The hybrid Sp-1 gave direct plaques and this suggested that
`it produces an lgM antibody. This is confirmed in Fig. 4 which
`shows the inhibition of SRBC lysis by a specific anti—IgM
`
`
`Table I Number of chromosomes in parental and hybrid cell lines
`
`Mean
`Number of chromosomes per cell
`Cell line
`65
`66,65,65,65,65
`P3-X67Ag8
`55
`Ref. 4
`Pl Bul
`40
`4
`Mouse spleen cells
`J06
`ll2,1l0,l04,l04,l02
`Hy-B(Pl—P3)
`90
`93,90,89,89,87
`Sp- 1 /7-2
`
`
`97,98,96,96,94,88Sp-2/3-3 95
`
`©1975 Nature Publishing Group
`
`

`
`Nature 1%)]. 256 August 7 I975
`
`Page 3
`
`49.,
`
`IEF techniques usually do not reveal 19S IgM
`antibody.
`IgM is
`therefore unlikely to be present
`in the
`molecules.
`unreduced sample a (Fig. 3B) but I1 chains should contribute
`to the pattern obtained after reduction (sample a, Fig. 3A).
`The above results show that cell fusion techniques are a
`powerful tool to produce specific antibody directed against a
`predetermined antigen. It further shows that it is possible to
`isolate hybrid lines producing different antibodies directed
`against the same antigen and carrying different effector func-
`tions (direct and indirect plaque).
`The uncloned population of P3~spleen hybrid cells seems
`quite heterogeneous. Using suitable detection procedures it
`should be possible to isolate tissue culture cell
`lines making
`different classes of antibody. To facilitate our studies we have
`used a myeloma parental line which itself produced an lg.
`Variants in which one of the parental chains is no longer ex-
`pressed seem fairly common in the case of P1—P3 hybrids
`(Fig. lh). Therefore selection oflines in which only the specific
`antibody chains are expressed seems
`reasonably simple.
`Alternatively, non-producing variants of myeloma lines could
`be used for fusion.
`We used SRBC as antigen. Three different fusion experiments
`were successful
`in producing a large number of antibody-
`producing cells. Three weeks after the initial fusion, 33/1,086
`
`'1
`
`
`
` ab
`
`b
`
`C
`
`
`
`Inhibition of haernolysis by antibody secreted by hybrid
`Fig. 4
`clone Sp-l/7-2. The reaction was in a 9-cm Petri dish with a layer
`of5 ml 0.6 % agarose in phosphate-buffered saline containing 1/80
`(v/v) SRBC. Centre well contains 2.5 ul 20 times concentrated
`culture medium of clone Sp-1/7-2 and 2.5 ul mouse serum. a,
`Sheep specific anti—mouse macroglobulin (MOPC 104E, Dr
`Feinstein); b, sheep anti-MOPC 21 (P3) IgGl absorbed with Adj
`PC-5; c, sheep anti-Adj PC-5 (IgG2a) absorbed with MOPC 21.
`After overnight incubation at room temperature the plate was
`developed with guinea pig serum diluted l:l0 in Dulbecco’s
`medium without serum.
`
`clones (3 "/,,) were positive by the direct plaque assay. The
`cloning efficiency in the experiment was 50 3/{,. In another experi-
`ment, however,
`the proportion of positive clones was con-
`siderably lower (about 0.2 ‘X,). In a third experiment the hybrid
`population was studied by limiting dilution analysis. From 157
`independent hybrids, as many as 15 had anti-SRBC activity.
`The proportion of positive over negative clones is remark-
`ably high.
`It
`is possible that spleen cells which have been
`triggered during immunisation are particularly successful
`in
`giving rise to viable hybrids. It remains to be seen whether
`similar results can be obtained using other antigenes.
`The cells used in this study are all of BALB/c origin and the
`hybrid clones can be injected into BALB/c mice to produce
`solid tumours and serum having anti-SRBC activity.
`It
`is
`possible to hybridise antibody-producing cells from different
`origins”. Such cells can be grown in vitro in massive cultures
`to provide specific antibody. Such cultures could be valuable
`for medical and industrial use.
`
`G. K6HLER
`C. MILSTEIN
`
`MRC Laboratory of Molecular Biology,
`Hills Road, Cambridge CB2 2QH, UK
`
`Received May 14; accepted June 26, I975.
`I Potter. M., Physiol. Rev., 52, 631-719 (1972).
`1 Horibata, K., and Harris. A. W., Exp] (‘(-11 Res.. 60. 61-70 (1970).
`3 Milstein. C.. and Munro, A. J.. in Defence and Recognition (edit. by Porter, R. R.),
`I99-228 (N/ITP Int. Rev. Sci., Butterworth, London, 1973).
`‘ Cotton. R. G. H., and Milstein. C., Nature. 244, 42-43 (1973).
`5 Schwaher, J., and Cohen, E. P., PI‘0('.I1(lN'l. A1-1:11.51-i. U.S.A., 7| . 2203-2207 ( I974).
`6 Littlefield, J. W., .S‘r'icnc-1». 145, 709 (1964).
`7 Svasti, J.. and Milstein, C.. Bioc/mm. J.. 128. 427-444 (1972).
`3 Milstein. C., Adetugbo, K., Cowan, N. .I., and Secher. D. 5.. Progress in Immuno-
`logy, ll,
`1 (edit. by Brent. L.. and Holborow, J.),
`I57-l68 (North-Holland.
`Amsterdam, I974).
`" Harris, H., and Watkins. J. F.. Nature, 205, 640-646 (1965).
`10 Awdeh, A. L., Williamson, A. R.. and Askonas. B. A., Nature, 219. 66-67 (1968).
`11 Milstein, C., Brownlee. G. G., Cartwright, E. M.. Janis. J. M.. and Proudfoot,
`N. 1., Nature. 252. 354-359 (1974).
`'2 Frangione, B.. and Milstein, C., Nature. 244. 597-599 (1969).
`1-‘ Jerne, N. K.. and Nordin. A. A.. S('i(’nz'z'. I40, 405 (1963).
`(1
`).
`N Cott;)_;13. R. G. H., Secher, D. S., and Milstein. (‘.. Eur. J. ImmIm., 3. 135-140
`
`Fig. 3 Autoradiograph of labelled components secreted by anti-
`SRBC specific hybrid lines. Fractionation before (8) and after (A)
`reduction was by IEF. pH gradient was 5.0 (bottom) to 9.0 (top)
`in the presence of6 M urea. Other conditions as in Fig. l.Super—
`natants from: a, hybrid clone Sp-1/7-2; /J, hybrid clone Sp-2/3-3;
`c, myeloma line P3-X67Ag8.
`
`©1975 Nature Publishing Group

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket